Emergent BioSolutions Inc

Emergent BioSolutions Inc is a leading global biopharmaceutical company that specializes in the development, manufacturing, and commercialization of vaccines and therapeutics for infectious diseases, oncology, and autoimmune disorders. The company's portfolio includes vaccines for anthrax, smallpox, and cholera, as well as treatments for opioid overdose and botulism. In addition, Emergent BioSolutions provides contract development and manufacturing services to other biopharmaceutical companies. The company is dedicated to improving public health and safety through innovative solutions and partnerships with government agencies, non-profit organizations, and other stakeholders. With headquarters in Maryland, USA, Emergent BioSolutions has a global presence with operations in the United States, Canada, Europe, and Asia.